Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $2.39 which represents a slight increase of $0.02 or 0.84% from the prior close of $2.37. The stock opened at $2.4 and ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.65% of ...
BTIG maintained its Buy rating and $190.00 price target for FTAI Aviation (NASDAQ: FTAI), which has demonstrated strong revenue growth of 36.77% over the last twelve months, despite recent challenges ...
Intuitive Surgical (NASDAQ:ISRG) shares maintained their Buy rating and a $561.00 price target from BTIG, despite potential ...
BTIG analyst David Larsen maintained a Buy rating on BrightSpring Health Services, Inc. (BTSG – Research Report) today and set a price target ...
BTIG analyst Marie Thibault reiterated a Buy rating on Masimo (MASI – Research Report) today and set a price target of $178.00. The company’s ...
BTIG Research’s target price would suggest a potential upside of 120.82% from the stock’s current price. Several other equities research analysts have also recently weighed in on the stock.
On Holding AG (NYSE:ONON – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Tuesday after Morgan Stanley raised their price target on the stock from $62.00 to $65.00 ...
to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology names. BTIG is increasing its estimates for U.S ...
BTIG initiated coverage of Cartesian Therapeutics ... the analyst tells investors in a research note. The firm says the company’s lead efforts are in myasthenia gravis, which has provided ...
Uber also pointed out that currency moves has worsened since its guidance was initially provided, the analyst tells investors in a research note. Uber has consistently met on bookings, and BTIG ...